GLO1 and type 1 diabetes mellitus: In the OVE26 mouse model of type 1 diabetes, it was shown that RAGE deficiency reduced glomerulosclerosis, improved renal function and this was accompanied by decreased MG and increased GLO1 expression (Reiniger et al. 2010).